FDA authorizes AstraZeneca antibody cocktail for immunocompromised people

The Food and Drug Administration (FDA) on Wednesday authorized AstraZeneca’s antibody cocktail designed to prevent COVID-19 in immunocompromised people who may not mount an adequate immune response to vaccines.The FDA granted AstraZeneca’s Evusheld...